BioScience Health Innovations (BHIC) Debt Ratio (2019 - 2022)

BioScience Health Innovations (BHIC) has 4 years of Debt Ratio data on file, last reported at 0.12 in Q2 2022.

• Debt Ratio for Q2 2022 came in at 0.12, down 99.73% year-over-year; the trailing twelve-month figure through May 2022 was 0.12 (down 99.73% YoY), and the FY2021 annual result was 2.76, up 628.89% from the prior year.
• Debt Ratio eased to 0.12 in Q2 2022 per BHIC's latest filing, from 0.18 in the prior quarter.
• Over five years, Debt Ratio peaked at 44.12 in Q2 2021 and troughed at 0.12 in Q2 2022.
• A 4-year average of 5.6 and a median of 0.73 in 2019 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2021 and 2022: Debt Ratio jumped 15667.37% in 2021, then plunged 99.73% in 2022.
• A 4-year view of Debt Ratio shows it stood at 0.76 in 2019, then slipped by 7.82% to 0.7 in 2020, then slumped by 74.23% to 0.18 in 2021, then slumped by 34.74% to 0.12 in 2022.
• Business Quant data shows BHIC's Debt Ratio at 0.12 in Q2 2022, 0.18 in Q4 2021, and 2.76 in Q3 2021.